Share “Bristol-Myers enters three-year...”

Bristol-Myers enters three-year collaboration deal

Published on NewsOK Modified: February 12, 2013 at 7:19 am •  Published: February 12, 2013
Advertisement

NEW YORK (AP) — Bristol-Myers Squibb Co. will receive more than $480 million from a collaboration agreement with British consumer goods company Reckitt Benckiser Group PLC over the sale of several over-the-counter drugs mostly in Mexico and Brazil.

The New York drug developer said Tuesday Reckitt Benckiser will pay $438 million upfront for exclusive rights to sell products like the antacid Picot, the pain reliever Tempra and the cold-and-cough medicine Graneodin over three years. Reckitt Benckiser will buy the products from Bristol and pay royalties during the collaboration.

The British company also will pay an option fee of $44 million for the right to buy the products outright at the end of the three-year agreement. That includes acquiring sales and distribution rights, trademarks, inventories and other assets. The purchase price then will be based on average sales during a two-year period before the deal closes.

Bristol-Myers Squibb shares finished at $36.93 on Monday.


AROUND THE WEB

  1. 1
    Sale of buried Atari cartridges nets over $107,000
  2. 2
    Bartender finds $20 bill, wins $1 million California lottery with it
  3. 3
    2 Maryland law enforcement dogs die of heat exhaustion inside car
  4. 4
    Blumenthal: John Boehner is 'alcoholic,' 'lazy,' 'banal' | Washington Examiner
  5. 5
    Emails: Hillary kept close ties to Clinton Foundation while at State | Washington Examiner
+ show more

FEATURED JOBS



× Trending business Article